| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Journal of Antimicrobial Chemotherapy (1993) 32, 379-392
© 1993 The British Society for Antimicrobial Chemotherapy
research-article |
Mechanisms of quinolone resistance in clinical isolates: accumulation of sparfloxacin and of fluoroquinolones of various hydrophobicity, and analysis of membrane composition
Centre National de la Recherche Scientifique CERCOA, BP 28, 94320, Thiais, France
Received 24 June 1992; returned 3 May 1993; accepted 3 May 1993
*Corresponding author.
The accumulation of sparfloxacin and three other fluoroquinolones of decreasing hydrophobicity, pefloxacin, ofloxacin, and ciprofloxacin, into randomly chosen fluoroquinolone-sensitive and -resistant clinical isolates of bacteria (four Enterobacteriaceae, one Pseudomonas aeruginosa and one Staphylococcus aureus) was measured. There was good correlation between the concentration of drug that inhibited early DNA synthesis in whole cells and the MIC values of the same drug regardless of organism sensitivity or the quinolone. A decrease in permeability in resistant strains compared with sensitive, due to a modification of outer membrane proteins was often involved in resistance. But, in all cases other mutations may also be involved explaining the relatively high level of resistance of the strains. In two resistant strains the DNA gyrase was purified and found to be resistant to inhibition by quinolones. The use of quinolones of differing hydrophobicity emphasized the importance of this property in the uptake of quinolones by bacterial cells, and provided evidence that sparfioxacin used both porin and the self-promoted uptake pathway for it's uptake.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
X. Yu, M. Susa, C. Knabbe, R. D. Schmid, and T. T. Bachmann Development and Validation of a Diagnostic DNA Microarray To Detect Quinolone-Resistant Escherichia coli among Clinical Isolates J. Clin. Microbiol., September 1, 2004; 42(9): 4083 - 4091. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Raherison, P. Gonzalez, H. Renaudin, A. Charron, C. Bebear, and C. M. Bebear Evidence of Active Efflux in Resistance to Ciprofloxacin and to Ethidium Bromide by Mycoplasma hominis Antimicrob. Agents Chemother., March 1, 2002; 46(3): 672 - 679. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Giraud, A. Cloeckaert, D. Kerboeuf, and E. Chaslus-Dancla Evidence for Active Efflux as the Primary Mechanism of Resistance to Ciprofloxacin in Salmonella enterica Serovar Typhimurium Antimicrob. Agents Chemother., May 1, 2000; 44(5): 1223 - 1228. [Abstract] [Full Text] [PDF] |
||||

